Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilett

Showing results (311-320 of 369) with videos related to

Pageof 37
Sort By:
Veterinary Immunology and Immunopathology|August 11, 2001
Cyclosporin immunosuppression of sheep: pharmacokinetics and allograft survivalA H Rose, K F Ilett, H L O'Donoghue, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2010
Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancyHarin A Karunajeewa, Sam Salman, Ivo Mueller, et al.
Antimicrobial Agents and Chemotherapy|March 1, 2017
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic ModelingSam Salman, Francisca Baiwog, Madhu Page-Sharp, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant womenHarin A Karunajeewa, Sam Salman, Ivo Mueller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2012
The efficacy versus toxicity profile of combination virotherapy and TLR immunotherapy highlights the danger of administering TLR agonists to oncolytic virus-treated miceDiana M Rommelfanger, Marta Compte, Marta C Grau, et al.
Princess Takamatsu Symposia|January 1, 1995
Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesisF Kadlubar, R K Kaderlik, G J Mulder, et al.
International Journal of Antimicrobial Agents|July 4, 2017
Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modellingSam Salman, Francesca Baiwog, Madhu Page-Sharp, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malariaT M Davis, H L Phuong, K F Ilett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2015
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune ResponsesKarishma Rajani, Christopher Parrish, Timothy Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 28, 2011
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapyTimothy Kottke, John Chester, Elizabeth Ilett, et al.
Pageof 37

Showing results (311-320 of 369) with videos related to

Sort By:
Pageof 37
Veterinary Immunology and Immunopathology|August 11, 2001
Cyclosporin immunosuppression of sheep: pharmacokinetics and allograft survivalA H Rose, K F Ilett, H L O'Donoghue, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2010
Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancyHarin A Karunajeewa, Sam Salman, Ivo Mueller, et al.
Antimicrobial Agents and Chemotherapy|March 1, 2017
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic ModelingSam Salman, Francisca Baiwog, Madhu Page-Sharp, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant womenHarin A Karunajeewa, Sam Salman, Ivo Mueller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2012
The efficacy versus toxicity profile of combination virotherapy and TLR immunotherapy highlights the danger of administering TLR agonists to oncolytic virus-treated miceDiana M Rommelfanger, Marta Compte, Marta C Grau, et al.
Princess Takamatsu Symposia|January 1, 1995
Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesisF Kadlubar, R K Kaderlik, G J Mulder, et al.
International Journal of Antimicrobial Agents|July 4, 2017
Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modellingSam Salman, Francesca Baiwog, Madhu Page-Sharp, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malariaT M Davis, H L Phuong, K F Ilett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2015
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune ResponsesKarishma Rajani, Christopher Parrish, Timothy Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 28, 2011
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapyTimothy Kottke, John Chester, Elizabeth Ilett, et al.
Pageof 37